Literature DB >> 16038531

Severe acute enteritis in a multiple myeloma patient receiving bortezomib and spinal radiotherapy: case report.

M M Mohiuddin1, D C Harmon, T F Delaney.   

Abstract

Proteasome inhibitors have been reported to enhance radiosensitivity in vitro. A case of potential clinical interaction between bortezomib, a proteasome inhibitor, and spine radiation is reported. A woman undergoing palliative radiotherapy to the T12 -S2 spine with concurrent bortezomib developed unexpectedly severe, acute radiation enteritis requiring hospital admission. Clinicians are advised to consider the potential for interactions of bortezomib with radiotherapy when the two agents are used simultaneously in the clinic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038531     DOI: 10.1179/joc.2005.17.3.343

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  4 in total

Review 1.  [Benefits of radiotherapy for patients with solitary plasmacytoma or multiple myeloma].

Authors:  Laila König; Klaus Herfarth
Journal:  Radiologe       Date:  2021-11-11       Impact factor: 0.635

2.  RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment.

Authors:  Andrea Emanuele Guerini; Alessandra Tucci; Filippo Alongi; Eneida Mataj; Angelo Belotti; Paolo Borghetti; Luca Triggiani; Ludovica Pegurri; Sara Pedretti; Marco Bonù; Davide Tomasini; Jessica Imbrescia; Alessandra Donofrio; Giorgio Facheris; Navdeep Singh; Giulia Volpi; Cesare Tomasi; Stefano Maria Magrini; Luigi Spiazzi; Michela Buglione
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

Review 3.  Clinical development of novel proteasome inhibitors for cancer treatment.

Authors:  Huanjie Yang; Jeffrey A Zonder; Q Ping Dou
Journal:  Expert Opin Investig Drugs       Date:  2009-07       Impact factor: 6.206

4.  The Safety Profile of Concurrent Therapy for Multiple Myeloma in the Modern Era.

Authors:  Lucas Resende Salgado; Shutao Wang; Ava Adler; Sanders Chang; Meng Ru; Erin Moshier; Kavita Dharmarajan; Hearn Jay Cho; Richard Bakst
Journal:  Adv Radiat Oncol       Date:  2018-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.